Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

SURVIVING TRIPLE-NEGATIVE BREAST CANCER: Hope, Treatment, and Recovery by Patricia Prijatel is exactly that—an encouraging guide to surviving a disease often referred to as, "a particularly ...

Triple-negative breast cancer (TNBC) doesn’t yet have targeted treatments, but it does respond much better to conventional chemotherapy than other breast cancer subtypes. Learn about recurrence ...

Family History and Metastatic Triple-Negative Breast Cancer (mTNBC) Treatment. All breast cancers are tough to get rid of once they’ve spread to other parts of your body.

March 3 marks Triple Negative Breast Cancer Awareness Day. Researchers and survivors have set the day apart to raise awareness to the rare form of breast cancer. TNBC survivor and foundation ...

A new discovery by the Cold Spring Harbor Laboratory could help point toward the first effective therapy for triple-negative breast cancer. Triple-negative breast cancer accounts for 10 to 15% of all ...

Sacituzumab govitecan combined with pembrolizumab improved progression-free survival in PD-L1–positive metastatic triple-negative breast cancer compared with chemotherapy. Vepdegestrant, a ...

The Triple Negative Breast Cancer Foundation supports people affected by TNBC and helps fund research in hopes of finding better treatment options and, one day, a cure. When 35-year-old Nancy ...

Holly was later diagnosed with Stage IIA Triple Negative Breast Cancer in the Spring of 2021. The National Institutes of Health (NIH) website states TNBC is responsible for 12% of breast cancers ...

Triple-negative breast cancer accounts for 10% to 15% of all breast cancer cases. It disproportionately affects younger and African American women, according to Cold Spring Harbor Laboratory.

Triple-negative breast cancer accounts for 10% to 15% of all breast cancer cases. It disproportionately affects younger and African American women, according to Cold Spring Harbor Laboratory.